ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,051.51
0.31%
US Tech 100
16,923.20
-0.36%
Dow Jones
38,100.52
0.75%
Brent Oil
83.475
-2.82%
Bitcoin
58,251.00
-3.88%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Femasys Inc (FEMY) Quote

Femasys Inc

Femasys Inc (FEMY)

NASDAQ
1.29
0.02
( 1.57% )
Updated: 14:21:19
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.29
Bid
1.29
Ask
1.31
Volume
60,280
1.27 Day's Range 1.34
0.2479 52 Week Range 4.75
Market Cap
28.145M
Previous Close
1.27
Open
1.27
Last Trade
100
@
1.29
Last Trade Time
14:21:19
Financial Volume
$ 79,468
VWAP
1.3183
Average Volume (3m)
749,588
Shares Outstanding
21,649,623
Dividend Yield
-
PE Ratio
-1.98
Earnings Per Share (EPS)
-0.66
Revenue
1.07M
Net Profit
-14.25M

About Femasys Inc

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in... Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.femasys.com
Headquarters
Dover, Delaware, USA
Founded
1970
Femasys Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker FEMY. The last closing price for Femasys was $1.27. Over the last year, Femasys shares have traded in a share price range of $ 0.2479 to $ 4.75.

Femasys currently has 21,649,623 shares outstanding. The market capitalization of Femasys is $28.14 million. Femasys has a price to earnings ratio (PE ratio) of -1.98.

FEMY Latest News

More News

Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives

ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

April 18 2024
GlobeNewswire Inc.

Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update

ATLANTA, March 28, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

March 28 2024
GlobeNewswire Inc.

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

ATLANTA, March 21, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing the significant unmet needs of women worldwide with a broad portfolio...

March 21 2024
GlobeNewswire Inc.

Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility

-- In the severe male factor cohort, findings show 24% of women became pregnant after FemaSeed -- -- FemaSeed pregnancy rate by cycle was more than double historic intrauterine insemination (IUI...

March 20 2024
GlobeNewswire Inc.

Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024

-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM...

March 13 2024
GlobeNewswire Inc.

Form 8-K - Current report

March 06 2024
Edgar (US Regulatory)

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

-- Paving the way forward for the broader commercial availability of FemaSeed, an accessible, safe, and cost effective alternative to IVF -- -- Ongoing uncertainty following recent Alabama Supreme...

March 06 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 28 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-3.731343283581.341.411.211017101.30071209CS
4-0.48-27.11864406781.771.841.212714161.43292902CS
120.414547.34437464310.87552.40.85117495881.64162965CS
26-0.19-12.83783783781.482.40.7347013811.32384336CS
520.4248.2758620690.874.750.247937544311.81034893CS
156-11.79-90.137614678913.0813.750.247913960231.92789368CS
260-11.79-90.137614678913.0813.750.247913960231.92789368CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTMXCytomX Therapeutics Inc
$ 4.48
(174.85%)
171.76M
SYTSYLA Technologies Company Ltd
$ 3.40
(132.88%)
11.09M
CYCCCyclacel Pharmaceuticals Inc
$ 3.5225
(66.16%)
11.85M
BCABBioAtla Inc
$ 3.11
(37.92%)
1.46M
APVOAptevo Therapeutics Inc
$ 0.9801
(37.91%)
3M
CETXCemtrex Inc
$ 0.319899
(-71.94%)
16.79M
CVRXCVRx Inc
$ 9.45
(-39.07%)
1.22M
BENFBeneficient
$ 2.30
(-30.72%)
178.53k
CGCCanopy Growth Corporation
$ 11.065
(-25.64%)
45.34M
GVVisionary Holdings Inc
$ 0.1905
(-25.59%)
681.62k
CTMXCytomX Therapeutics Inc
$ 4.48
(174.85%)
171.76M
AKANAkanda Corporation
$ 0.1132
(21.72%)
171.73M
SQQQProShares UltraPro Short QQQ
$ 12.1082
(1.32%)
107.76M
TLRYTilray Brands Inc
$ 2.035
(-17.61%)
79.7M
AMDAdvanced Micro Devices Inc
$ 143.88
(-9.16%)
61.7M

FEMY Discussion

View Posts
TripTrap TripTrap 2 days ago
$FEMY Today might not have seemed like anything special but technically it was an inside day and closed near the high of the day... Going to be watching for a good follow through up tomorrow!! LFG!! 🔥🔥🚀
👍️0
Monksdream Monksdream 2 days ago
FEMY under $2
👍️0
Monksdream Monksdream 2 days ago
FEMY under $2
👍️0
TripTrap TripTrap 1 week ago
$FEMY Love what I am seeing today...busting up through the $1.36 equal highs flat area!! Who have thunk it?? LFG!!!! 🔥🔥🚀
👍️0
TripTrap TripTrap 1 week ago
$FEMY Nice equal highs flat area @ $1.36 we will bust up through soon IMO...perhaps on Wednesday.
👍️0
TripTrap TripTrap 1 week ago
$FEMY Starting to look like a bottom to me on all time frames...finally! Here is a 4 hour chart... 🔥🔥🚀
👍️0
TripTrap TripTrap 2 weeks ago
$FEMY - Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives!!🔥🔥 https://www.stocktitan.net/news/FEMY/femasys-ceo-and-founder-kathy-lee-sepsick-meets-with-members-of-2cnl15sg8dnx.html
👍️0
TripTrap TripTrap 2 weeks ago
$FEMY Bottoms are often lonely places...just say'in...
👍️0
TripTrap TripTrap 2 weeks ago
$FEMY - So we did indeed take out $1.27 and also kissed the daily 250 EMA at $1.26...Dare I say the bottom may be in place. It's likely If we get a strong close today...
👍️0
TripTrap TripTrap 2 weeks ago
$FEMY We will need to go down just a bit more before we make the turn back up. There is a flat equal lows inter-day at $1.27 that they will need to penetrate down through. Bottoms are almost always pointy places, not flat areas...
👍️0
TripTrap TripTrap 2 weeks ago
$FEMY 4-hour chart. Bottom is near...betting we turn back up Monday/Tuesday! LFG!!! 🔥🔥🚀
👍️0
TripTrap TripTrap 3 weeks ago
$FEMY - unfortunately bottom not quite in place yet IMO. New intra-day flat area at $1.27. Expect Monday or Tuesday to breakdown though $1.27 and start to bounce off the 250 EMA around $1.25 or there abouts. 4 hour RSI now buried below the 30 RSI value...It screams "bottom is near" knowing how strong the fundamentals are for FEMY!
👍️0
TripTrap TripTrap 3 weeks ago
$FEMY 4 hour chart - Intrauterine Insemination Devices Market revenue to hit USD 62 Billion by 2035, says Research Nester! FemaSeed pregnancy rate by cycle was MORE THAN DOUBLE HISTORIC IUI RATE!!!!
👍️0
TripTrap TripTrap 4 weeks ago
$FEMY 15 Min chart - Expect to see price down first / then up out of the box and then up to fill the gap. Then expect to see much higher prices as traders/customers wake up to what is going on with this company....namely disrupting the entire infertility reproductive space!
👍️ 1
TripTrap TripTrap 4 weeks ago
$FEMY Breakout today up above the important 15 min 250 EMA that I mentioned last Thursday on the 28th...
👍️ 1
TripTrap TripTrap 1 month ago
$FEMY Was just doing some research... The IUI market revenue alone is expected to hit US$62 Billion by 2035 worldwide according to Research Nester. FemaSeed has GINORMOUS potential once word gets out since it looks to be a better solution then IUI..,ie higher success rate and less expensive. IUI technology works with placing sperm inside the uterus. Femasys is the only company using the FemaSeed technology to deliver sperm directly inside a woman's fallopian tubes where conception actually takes place!!
👍️0
TripTrap TripTrap 1 month ago
$FEMY 4/1/2024 6:53am --HC Wainwright Adjusts Femasys' Price Target to $12 From $10, Reiterates Buy Rating That would be a 689% increase from $1.52 where we are now to $12.00.
👍️0
TripTrap TripTrap 1 month ago
$FEMY NEWS OUT!! 3/28/24 16:05 ET| Femasys Announces 2023 Financial Results and Provides Corporate Update Following FDA Clearance of FemaSeed® - FEMY Secures Capital to Support Commercial Initiatives; Cash Expected to Fund Operations Into 2H 2025...
https://www.globenewswire.com/news-release/2024/03/28/2854473/0/en/Femasys-Announces-Financial-Results-for-Year-Ended-December-31-2023-and-Provides-Corporate-Update.html
👍️0
TripTrap TripTrap 1 month ago
$FEMY 15 Min Chart - Amazing how well price respects the 15 min, 250 EMA on FEMY (day session only) going back over time. When you find a moving average like this that works well for a stock, it's a good idea to keep an eye on it. Looking at the average now we NEED TO GET UP ABOVE THE $1.66 AREA, to know we are out of the woods so to speak...
👍️0
TripTrap TripTrap 1 month ago
$FEMY So no news yet this morning. Perhaps the 10-K will come out after the market closes to give traders the long weekend to mull it over and react come Monday? I just don't know...
👍️0
TripTrap TripTrap 1 month ago
$FEMY So oversold it's ridiculous. We blew down through the 50% fib and likely have found a bottom right at the 61.8% fib line. This seems to be the area where the pro-traders want to take it down to before tomorrow's earnings/guidance.
👍️0
TripTrap TripTrap 1 month ago
FEMY Just so we are all clear… Cathy, Lee Sepsick, the CEO, said during the “fireside chat“ that earnings/guidance will be coming out tomorrow, Thursday…. “We are going to have our K released on March 28th” … meaning the 10-K. Because of that, I’m guessing we should expect some pretty volatile price action today… Especially this morning and the last half hour of the day because I believe the 10-K will be out in the morning before the bell tomorrow. Professional traders will do everything to scare you out of your shares… I think the 10-K is going to be quite positive (not the earnings part of it) but the PR that will be released with it because they will be spelling out their plans and goals for the next 12 months and something tells me they’re going to be quite aggressive with the new CCO on board… Holding tight!!
👍️0
TripTrap TripTrap 1 month ago
$FEMY 3/26/24 Daily Chart - We have the 50% fib and the 50 day EMA in close confluence to each other. Would expect to see price drop down between $1.56 - $1.47 first before we start to rebound in anticipation for earnings and guidance this Thursday.
👍️0
TripTrap TripTrap 1 month ago
$FEMY Anticipating one more day of tough sledding getting down around the $1.55-$1.50 area. Then start to turn things around on turnaround Tuesday as we begin the climb into earning and guidance expected to come out this Thursday... Will see how it goes! Super bullish, holding tight!!
👍️0
TripTrap TripTrap 1 month ago
$FEMY - traders will continue to screw around with price between now and next Thursday IMO when earnings/guidance comes out...Expect them to take price down through the daily flat area of $1.62 posted on my chart yesterday...great opportunity around the $1.57 50% fib area IMO...Bullish as hell long term!!!!
👍️0
TripTrap TripTrap 1 month ago
iHub...how do I become a moderator on this board? I see no place up top to submit a request...
👍️0
TripTrap TripTrap 1 month ago
The conference just ended. I am not a medical person but did come away with a sense that we are in very good hands. Solid management in place. They have cash through 2nd half of 2025 and will proceed with "any non-dilutive" means to add capital. They have a lot of plans to push FemaSeed out to the market in 2024 under the guidance of their new CCO. They have a huge edge as FemaSeed is a lot less expensive, safer and the majority of the time works on the first go round (cycle), (if it's going to work), bringing costs down. Will wait and see what the 10K brings us next week.
👍️0
BurgerKing82 BurgerKing82 1 month ago
Is it still going?... Anything else interesting?
👍️0
TripTrap TripTrap 1 month ago
Okay.. FEMY CEO just said March 28th is when 10K is coming out..
👍️0
TripTrap TripTrap 1 month ago
Cool…no problem…we disagree. FEMY is no rink dink fly by night destined to never turn a profit company. Quite the opposite… FEMY is going to completely disrupt the ginormous and growing infertility AND permanent sterilization space!! You can etch THAT in stone…
👍️0
Monksdream Monksdream 1 month ago
I absolutely 100 percent etched in stone disagree
👍️0
TripTrap TripTrap 1 month ago
Okay...thanks for the source...I will check it out.! BTW...all companies are "rink dink" when they are just starting out. This is not OTC land... FEMY is on the NASDAQ for a reason!!
👍️0
Monksdream Monksdream 1 month ago
My source is Seeking Alpha
These rink dink money losing nanocaps rarely set a definitive date
👍️0
TripTrap TripTrap 1 month ago
Did FEMY announce somewhere that the 10Q was due 3/22 ??
👍️0
TripTrap TripTrap 1 month ago
$FEMY In light of the idiotic price action after the good news yesterday....here is where we should find support...
👍️0
Monksdream Monksdream 1 month ago
FEMY 10Q due 3/22
👍️0
TripTrap TripTrap 1 month ago
$FEMY REMINDER - TODAY 1pm ET 3/21/24 -CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed®. Link to register in article.
https://www.biospace.com/article/releases/femasys-to-participate-in-fireside-chat-to-discuss-the-infertility-treatment-landscape-on-march-21-2024/
👍️0
BurgerKing82 BurgerKing82 1 month ago
I didn't expect news today....But definitely responded logically...Not sure what to expect tomorrow/Friday...Depends on what is said...Don't think much will happen in either direction...a small pop maybe...
👍️0
TripTrap TripTrap 1 month ago
$FEMY Traders playing games after GREAT news out!
This morning's down gap WILL GET FILLED IN and price will go much higher IMO!!
👍️0
TripTrap TripTrap 1 month ago
$FEMY With the results that came out, traders can only play games with share price for so long:
👍️0
TripTrap TripTrap 1 month ago
$FEMY NEWS OUT: Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
--FemaSeed pregnancy rate by cycle was more than double historic intrauterine insemination (IUI) rate!!!
--Of those with a successful pregnancy, a majority required only one FemaSeed procedure!!!
--No new safety concerns were reported!!!
https://www.biospace.com/article/releases/femasys-announces-positive-topline-data-from-pivotal-trial-for-its-fda-cleared-femaseed-for-the-treatment-of-infertility/
👍️0
BurgerKing82 BurgerKing82 1 month ago
Is it really surprising....news was anticipated already,no?
👍️0
TheFinalCD TheFinalCD 1 month ago
wow 1.85 no way the stock market is upside down
👍️0
TheFinalCD TheFinalCD 1 month ago
FEMY 1.99 this is so aggravating

pops to 2.50 on good news

then pushed back

meanwhile shit like BCAN and ETAO fly high on delisting pump
👍️0
TheFinalCD TheFinalCD 1 month ago
16 seconds late...

lol just kiddin
👍️0
Awl416 Awl416 1 month ago
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
👍️0
TheFinalCD TheFinalCD 1 month ago
$femy news Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility $FEMY https://t.co/97jcU1KGBa— Health Stocks News (@health_stocks) March 20, 2024

https://dilutiontracker.com/app/search/FEMY

https://finviz.com/quote.ashx?t=FEMY&ty=c&ta=1&p=d
👍️0
TripTrap TripTrap 1 month ago
$FEMY Ready to fly...
👍️0
Monksdream Monksdream 2 months ago
FEMY under $2
👍️0
TripTrap TripTrap 2 months ago
$FEMY Daily - Fibonacci support area:
👍️0

Your Recent History

NASDAQ
FEMY
Femasys
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved